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INTRODUCTION
Antineutrophil cytoplasmic antibody (ANCA)-associated vas-
culitis (AAV) is a group of vasculitides mainly affecting small 
vessels from capillaries to intraparenchymal arteries. AAV con-
sists of three variants including microscopic polyangiitis (MPA), 
granulomatosis with polyangiitis (GPA), and eosinophilic 
granulomatosis with polyangiitis (EGPA).1 AAV can affect vari-
ous organs, including the kidneys, lungs, and peripheral nerves. 
Among these, lung (chest) manifestations are described as 
wheeze, nodules or cavities, pleurisy, infiltrate, endobronchial 
involvement, alveolar haemorrhage, and respiratory failure.2,3 
In patients with AAV, the rate of lung involvement ranges from 
20% to 80% according to AAV variants: 60–80% for MPA, 20–
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60% for GPA, 34–56% for ANCA-positive EGPA and 60–76% for 
ANCA-negative EGPA.4 The major pulmonary symptoms re-
lated to AAV are progressive dyspnoea (50–73%) and cough 
(21–60%), and are accompanied by constitutional and extra-
pulmonary symptoms at a rate of approximately 80%.5 In ad-
dition, previous studies have indicated that lung involvement 
has an unfavourable impact on long-term prognosis and re-
lapse rate in AAV patients.6-8 
Chest computed tomography (CT) patterns of lung paren-
chymal lesions related to AAV include ground glass opacities, 
reticular shadowing, interlobular septal thickening, consolida-
tion and honeycomb appearance. Of these findings, the most 
common chest CT pattern is unusual interstitial pneumonia 
(UIP), followed by non-specific interstitial pneumonia (NSIP).5,6 
The histological features on surgical lung biopsy depend on the 
subtype of AAV. The typical pathologic findings in GPA are nec-
rotizing granuloma vasculitis involving adventitia, media of small 
vessels; lung biopsies from EGPA patients display eosinophilic 
vasculitis or eosinophilic granuloma; and the histological find-
ings in MPA are typically pulmonary haemorrhage, hemosid-
erin-laden macrophages in the alveolar space and neutrophil-
ic capillaritis.7 
When lung parenchymal lesions are suspected on chest X-
ray (CXR) or chest CT, a surgical lung biopsy is a standard test 
to confirm lung involvement of AAV. However, lung biopsy is 
an invasive and risky procedure, such that it cannot be recom-
mended in all patients suspected of lung involvement of AAV. 
Thus, in clinical settings, biopsies targeting other organs such 
as the kidneys, nerves and maxillary sinus are performed be-
fore lung biopsy to diagnose AAV. For these reasons, previous 
studies have been unable to clearly answer questions on wheth-
er histological features of lung involvement are AAV variant-
specific and how different the rates of consistency between 
radiological and histological features are among MPA, GPA 
and EGPA. Furthermore, to the best of our knowledge, there has 
been no report on the consistency between radiological and 
histological features in AAV patients in Korea. Hence, in this 
study, we investigated the chest CT patterns of 74 AAV patients 
and analysed both histological features of lung involvement 
and the rate of consistency between radiological and histologi-
cal features among MPA, GPA, and EGPA in 28 AAV patients 
who underwent lung biopsy within 4 weeks before and after 
diagnosis of AAV. 
MATERIALS AND METHODS
Patients
We retrospectively reviewed the medical records of 145 pa-
tients with AAV (83 MPA, 31 GPA, and 31 EGPA patients) who 
had CXR results at diagnosis, according to the following inclu-
sion criteria: 1) patients who were first classified as having AAV 
from October 2000 to May 2017 at the Division of Rheumatol-
ogy, Department of Internal Medicine, Yonsei University Col-
lege of Medicine, Severance Hospital; 2) patients with MPA 
who fulfilled the algorithm suggested by the European Medi-
cines Agency (EMA) in 2007 (the 2007 EMA algorithm) and 
the Chapel Hill Consensus Conference (CHCC) Nomenclature 
of Vasculitides proposed in 2012 (the 2012 CHCC definitions);1,9 
3) patients with GPA and EGPA who met the 1990 American 
College of Rheumatology (ACR) classification criteria for GPA 
and EGPA, the 2007 EMA algorithm and the 2012 CHCC defi-
nitions.1,9-11 Also, we only included patients who had positive 
results of ANCA at diagnosis and had well-summarised medi-
cal records at the time of lung evaluation for assessing organ-
based manifestations based on Birmingham Vasculitis Activity 
Score (BVAS).2,3 Among 145 patients with AAV who had CXR 
at diagnosis, we enrolled 74 patients who underwent chest CT 
due to abnormalities on CXR. Of these, 28 underwent a surgi-
cal lung biopsy with concerns for lung involvement of AAV on 
chest CT. We reviewed the histological features of AAV and in-
vestigated consistency with histological features expected by the 
CT pattern in 28 of 74 AAV patients, who had results of lung bi-
opsy (Fig. 1). This study was approved by the Institutional Re-
view Board of Severance Hospital (4-2017-0673).
Clinical and laboratory data 
We obtained age and gender as demographic data. Perinuclear 
(P)-ANCA and cytoplasmic (C)-ANCA were evaluated by im-
munofluorescence assay. Myeloperoxidase (MPO)-ANCA and 
proteinase 3 (PR3)-ANCA were measured by enzyme-linked 
immunosorbent assay (ELISA) kits for anti-PR3 and anti-MPO 
(Inova Diagnostics, San Diego, CA, USA) before 2013, and by the 
46 patients were excluded 
due to the absence of lung 
histological results
71 patients were excluded 
due to the absence of lung 
parenchymal lesions
145 patients with ANCA-associated vasculitis 
having results of chest X-ray at diagnosis
74 patients with ANCA-associated vasculitis 
having results of chest computed tomography
28 patients with ANCA-associated vasculitis 
having lung histological results at diagnosis
Fig. 1. Selection of the study population. ANCA, antineutrophil cytoplas-
mic antibody. 
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novel anchor coated highly sensitive (hs) Phadia ELiA (Thermo 
Fisher Scientific/Phadia, Freiburg, Germany) using human 
native antigens, performed on a Phadia250 analyser after 2013. 
We reviewed the coexistence of autoimmune diseases, which 
can present lung parenchymal lesions similar to those of AAV. 
We calculated the BVAS and assessed organ-based clinical 
manifestations described in the BVAS. We also collected results 
of pulmonary function test including forced volume vital capac-
ity (FVC), forced expiratory volume in 1 second (FEV1) and dif-
fusing capacity of the lung for carbon monoxide (DLCO). 
Chest CT patterns and histological features 
Among 74 patients who underwent chest CT, 28 patients re-
ceived a lung biopsy within 1 month before and after diagno-
sis of AAV. We divided chest CT patterns into 12 items which 
were mostly suggested by radiologists and were assessed as the 
frequency of each item: lung involvement of vasculitis (vasculi-
tis); interstitial lung disease (ILD), including UIP, NSIP, and 
other ILD (not UIP or NSIP); pneumonia including bacterial 
or viral, tuberculosis or non-tuberculous mycobacterial and 
fungal pneumonia; post-inflammatory change; diffuse alveo-
lar haemorrhage (DAH); resolved DAH; lung cancer and un-
classified lung parenchymal lesions. We divided histological 
features compatible with AAV into 4 items as determined by a 
pathologist: necrotizing granuloma, necrotizing vasculitis, eo-
sinophilic infiltration and hemosiderin-laden macrophage. 
We then evaluated the rate of consistency between radiological 
and histological features among the AAV variants. We also col-
lected the pathologic results of other organs affected by AAV to 
confirm the vasculitis. 
Statistical analyses 
All statistical analyses were conducted using SPSS software 
(version 23 for Windows; IBM Corp., Armonk, NY, USA). Con-
tinuous variables are expressed as a mean±standard deviation, 
and categorical variables are reported as a number and per-
centage. 
RESULTS
Baseline characteristics of 74 patients with AAV 
patients with chest CT results suggesting lung 
parenchymal lesions 
The baseline characteristics are described in Table 1. The mean 
age was 57.1 years and 22 patients were male. The 74 AAV pa-
tients presented with 44 MPA, 15 GPA and 15 EGPA in this 
study. Fifty-four patients (73.0%) had MPO-ANCA (or P-AN-
CA) and 7 (9.5%) had PR3-ANCA (or C-ANCA). Four patients 
(5.4%) had MPO-ANCA (or P-ANCA) as well as PR3-ANCA (or 
C-ANCA). Eight patients had concurrent autoimmune diseas-
es that can provoke lung parenchymal lesions similar to those 
of AAV: 3 patients had Sjogren syndrome, 2 had systemic scle-
Table 1. Baseline Characteristics of 74 Patients with AAV and with Chest 
CT Results Suggesting Lung Parenchymal Lesions at Diagnosis
Variables Values
Demographic data 
Age (yr) 57.1±14.2
Male gender 22 (29.7)
Variants of AAV
MPA 44 (59.5)
GPA 15 (20.3)
EGPA 15 (20.3)
ANCA
MPO-ANCA (or P-ANCA) 54 (73.0)
PR3-ANCA (or C-ANCA) 7 (9.5)
MPO-ANCA (or P-ANCA) and PR3-ANCA (or C-ANCA) 4 (5.4)
ANCA negative 9 (12.1)
Autoimmune diseases other than AAV
Sjogren syndrome 3 (2.7)
Systemic sclerosis 2 (2.7)
Systemic lupus erythematosus 1 (1.4)
Mixed connective tissue disease 1 (1.4)
Rheumatoid arthritis 1 (1.4)
Clinical manifestations other than lung involvement
Renal manifestation 46 (62.2)
General manifestation 42 (56.8)
Ear nose throat manifestation 24 (32.4)
Cardiovascular manifestation 24 (32.4)
Nervous systemic manifestation 22 (29.7)
Cutaneous manifestation 15 (20.3)
Mucous membranes/Eyes manifestation 4 (5.4)
Gastrointestinal manifestation 4 (5.4)
BVAS or BVAS for GPA 13.3±7.5
Pulmonary function test 
FVC (%) (n=42) 83.6±19.5
FEV1 (%) (n=42) 87.1±24.9
DLCO (%) (n=28) 81.9±21.4
Major findings on chest CT
Reticular shadow 13 (17.6)
Honeycomb 15 (20.3)
Nodule 11 (14.9)
Cavity 2 (2.7)
Ground glass opacity 21 (28.4)
Consolidation 10 (13.5)
Unspecified 2 (2.7)
Chest CT patterns mostly suggested
Lung involvement of vasculitis (vasculitis) 26 (35.1)
ILD 24 (32.4)
UIP 13 (17.6)
NSIP 6 (8.1)
Others 5 (6.8)
Pneumonia 13 (17.6)
Bacterial or viral 9 (12.2)
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rosis, 1 had systemic lupus erythematosus, 1 had mixed con-
nective tissue disease, and 1 had rheumatoid arthritis. The most 
common clinical manifestation other than lung was renal mani-
festation (62.2%), followed by general (56.8%), ENT (32.4%), 
and cardiovascular (32.4%) manifestations. The initial mean 
BVAS was 13.3. Ground glass opacity (28.4%) was the most 
common major finding on chest CT, followed by honeycomb 
(20.3%), reticular shadow (17.6%), and nodule (14.9%). The 
most common chest CT pattern was lung involvement of vascu-
litis (35.1%), followed by ILD (32.4%) and pneumonia (17.6%). 
Among ILD, UIP (17.6%) was the most commonly observed 
chest CT pattern, and among pneumonia, bacterial pneumo-
nia (12.2%) was most frequently observed. Pulmonary func-
tion test showed that mean FVC and FEV1 were 83.6% and 
87.1% and that mean DLCO was 81.9%. 
Lung histology and consistency rate between 
radiological and histological features
Forty-six of 74 patients were suspected lung involvement of 
AAV but did not undergo lung biopsy for the following reasons: 
AAV was confirmed from other organ tissues in 27 patients 
(58.7%), biopsy was refused in 9 (19.6%), pneumonia was ex-
pected to be aggravated after lung biopsy in 5 (10.9%), and 5 pa-
tients expired (10.9%). Among 14 MPA patients, 6 patients ex-
hibited chest CT findings suggesting vasculitis, whereas 6 
patients exhibited histological features of AAV. On histology, he-
mosiderin laden macrophage was observed in 3 MPA patients 
and necrotising vasculitis was noted in 3 MPA patients. Only 4 
of 6 patients with histological evidence of AAV had chest CT 
findings suggesting vasculitis. Thus, the consistency rate be-
tween radiological and lung histological findings was 66.7% in 
MPA patients. All 9 GPA patients exhibited both chest CT and 
lung histological findings of AAV. On histology, necrotising 
granuloma, necrotising vasculitis and eosinophilic infiltration 
were observed in 6, 9, and 1 GPA patients, respectively. Thus, 
the consistency rate between radiological and lung histologi-
cal findings was 100% in GPA patients. Meanwhile, among 5 
EGPA patients, 2 patients exhibited necrotising vasculitis on 
histology and furthermore 1 of 2 patients had chest CT findings 
suggesting vasculitis. Thus, the consistency rate between radio-
logical and lung histological findings was 50.0% in EGPA pa-
tients (Table 2). 
DISCUSSION
In this study, we investigated chest CT patterns in 74 AAV pa-
tients and analysed both the histological features of lung in-
volvement and the consistency between radiological and histo-
logical results in 28 AAV patients who underwent lung biopsy 
according to AAV variants. Of 145 patients who had results of 
CXR at diagnosis of AAV, 74 patients (51.0%) underwent chest 
CT. The most frequent extra-pulmonary manifestation of them 
was renal manifestation, followed by general manifestation. 
Similarly, previous reports revealed that patients with AAV ex-
hibited kidney-related symptoms in up to 100% and constitu-
tional symptoms in approximately 80%.5
In this study, we founded that lung histological features dif-
fer among AAV variants. In MPA patients, the major histologi-
cal features were necrotizing vasculitis and hemosiderin-laden 
macrophages in MPO-ANCA positive patients, and none ex-
hibited necrotising granuloma or eosinophilic infiltration in 
lung tissues. Meanwhile, in GPA patients, the major histologi-
cal features were necrotizing vasculitis and necrotizing granu-
loma, and the major histological feature of EGPA patients was 
only necrotizing vasculitis. 
The consistency rates between radiological and lung histo-
logical findings were based on AAV variants. The consistency 
rate in GPA patients was the highest (100%), followed by that 
in MPA patients (66.7%) and EGPA patients (50.0%). Two pa-
tients suspected of vasculitis on chest CT had no evidence of 
AAV on lung histology but they were finally classified as MPA 
by renal histological findings. Interestingly, 1 patient suspect-
ed of other ILD and 1 patients suspected of pneumonia exhibit-
ed histological features of MPA. Meanwhile, 1 of 2 EGPA patients 
with histological features compatible with AAV was suspected 
of pneumonia, rather than AAV on chest CT. Therefore, in MPA 
Table 1. Baseline Characteristics of 74 Patients with AAV and with Chest 
CT Results Suggesting Lung Parenchymal Lesions at Diagnosis (Continued)
Variables Values
Tuberculosis or non-tuberculous mycobacterial 3 (4.1)
Fungal 1 (1.4)
Post-inflammatory change 4 (5.4)
Diffuse alveolar haemorrhage 2 (2.7)
Resolved diffuse alveolar haemorrhage 2 (2.7)
Unclassified lung parenchymal lesion 2 (2.7)
Lung cancer 1 (1.4)
Reasons for no performance of lung biopsy (n=46)
Other vasculitis-confirming biopsy 27 (58.7)
Kidney 18 (39.1)
Nerve 6 (13.0)
Nasal cavity 2 (4.3)
Skin 1 (2.2)
Refusal 9 (19.6)
Pneumonia 5 (10.9)
Death during the same period of hospitalisation as chest CT 
performance 
5 (10.9)
AAV, ANCA-associated vasculitis; CT, computed tomography; MPA, micro-
scopic polyangiitis; GPA, granulomatosis with polyangiitis; EGPA, eosinophilic 
granulomatosis with polyangiitis; MPO, myeloperoxidase; ANCA, antineutro-
phil cytoplasmic antibody; P-ANCA, perinuclear ANCA; PR3, proteinase 3; C-AN-
CA, cytoplasmic ANCA; BVAS, Birmingham Vasculitis Activity Score; FVC, forced 
volume vital capacity; FEV1, forced expiratory volume in 1 second; DLCO, diffusing 
capacity of the lung for carbon monoxide; ILD, interstitial lung disease; UIP, usu-
al interstitial pneumonia; NSIP, non-specific interstitial pneumonia. 
Values are expressed as mean±standard deviation or n (%). 
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and EGPA patients, when lung involvement of AAV is suspected 
on chest CT, lung biopsy should be recommended for proper 
classification of AAV, due to discordance between radiological 
and histological findings. 
While radiological features on chest CT could suggest GPA, 
physicians should not put blind belief in chest CT patterns 
showing cavitary lung parenchymal lesions before the final 
classification of AAV. It could be reasonably speculated that 
lung cavitary parenchymal lesions are important predictive 
clues for GPA. However, one patient with MPA who exhibited 
cavitary parenchymal lesions in chest CT was finally confirmed 
to have a fungal infection on lung biopsy. In this case, MPA 
was confirmed by MPO-ANCA positivity and renal biopsy. 
Furthermore, the aspergillosis antigen was detected in the se-
rum of this patient and typical Aspergillus hyphae was observed 
on lung histology.12,13 The halo sign in chest CT images has 
been used to discern the aetiologies of pulmonary cavitary 
nodules; however, this can be observed in various diseases 
beyond GPA, including invasive aspergilloma.14 Herein, three 
of 9 GPA patients who exhibited cavitary lesions in chest CT 
underwent lung biopsy to exclude other lung pathologic con-
ditions including fungal infection despite the presence of his-
tology of nasal cavity compatible with GPA in our study.15 
One MPA patient and one EGPA patient had overlapping syn-
dromes with AAV and Sjogren syndrome. Both patients had an-
ti-SSA/Ro antibody and decreased lacrimal and salivary gland 
function. In these patients, chest CT mostly suggested UIP, and 
lung biopsies revealed patchy interstitial fibrosis with honey-
comb change, which was consistent with a UIP pattern, with 
many lymphoid follicles.16,17 When AAV was accompanied by 
autoimmune connective tissue disease, at least confined to this 
study, lung histology did not seem helpful to confirm vasculitis. 
Also, lung biopsy alone could not confirm AAV when chest CT 
showed diffuse ground glass opacity lesions suggestive of ILD, 
pulmonary haemorrhage, and atypical pneumonia in patients 
with AVV. Meanwhile, the diagnosis of MPA was usually made 
through kidney biopsy, and that of EGPA was done through 
nerve biopsy. However, physicians should consider a lung bi-
opsy, because other aetiologies, such as fungal infection, tu-
berculosis and lung cancer, must be excluded before treatment 
for AAV. 
The administration of glucocorticoid before lung biopsy 
may have an influence on histological features of lung paren-
chyma and may confuse the precise classification of AAV. There-
fore, we reviewed the medical records of 28 AAV patients who 
underwent lung biopsy and counted the number of patients 
who received glucocorticoids before lung biopsy. Glucocorti-
coids were administered to five MPA patients before lung bi-
opsy. Two of the five MPA patients had previously received 
glucocorticoids due to DAH. Four of the five patients exhibited 
histological features compatible with MPA, while one patient 
did not. Thus, we assume that the administration of glucocorti-
coid might hide the histological features of AAV in MPA patients 
who exhibit ground-glass opacity on chest CT, despite the 
small number of patients and the retrospective study design.
Our study has merit in that we, for the first time, described 
both histological and radiological features in the same AAV 
patients, compared them and assessed the consistency be-
tween them in all variants of AAV. However, our study also has 
several limitations: First, we retrospectively reviewed medical 
records of AAV patients, which prohibited us from interpret-
ing radiological features with more information, particularly 
clinical symptoms and signs at diagnosis. Second, only 28 of 
74 patients who exhibited abnormal lung parenchymal find-
ings on chest imaging studies underwent lung biopsy because 
of various clinical reasons. Accordingly, we believe that addi-
tional cases of lung biopsy could have further clarified the link 
between radiological and histological information in AAV pa-
tients.
In conclusion, the consistency rate in GPA patients was the 
highest (100%), followed by that in MPA patients (66.7%) and 
EGPA patients (50.0%). Therefore, in MPA and EGPA patients, 
when lung involvement of AAV is suspected on chest CT, lung 
biopsy should be recommended for the proper classification 
of AAV, due to discordance between radiological and histo-
logical findings.
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